Physician profile
Brian E Pucevich
NPI 1295998557
$13,929.35
in general payments reported to CMS, 2019-2025
40 companies · $1,737 in 2025
The $1,737 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,479 · 2020: $1,575 · 2021: $2,340 · 2022: $1,931 · 2023: $1,745 · 2024: $2,123 · 2025: $1,737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,504 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,504.14 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $2,753.62 | 2019-2025 | Tremfya, Stelara, Simponi Aria |
| Abbvie INC. | $1,718.39 | 2019-2025 | |
| Lilly USA, LLC | $1,173.01 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Amgen INC. | $899.97 | 2019-2025 | Otezla, Otezla |
| Novartis Pharmaceuticals Corporation | $797.96 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $790.48 | 2019-2025 | Blu-U, Odomzo, Ilumya |
| Genzyme Corporation | $763.09 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $631.06 | 2022-2025 | Sotyktu |
| Pfizer INC. | $453.97 | 2019-2025 | |
| Ucb, INC. | $446.61 | 2019-2025 | Bimzelx, Cimzia |
| Regeneron Healthcare Solutions, INC. | $384.52 | 2019-2025 | Dupixent, Libtayo |
| Prugen, INC. Pharmaceuticals | $346.91 | 2019 | |
| Incyte Corporation | $308.16 | 2021-2025 | Opzelura |
| Leo Pharma INC. | $264.49 | 2020-2025 | Anzupgo, Adbry |
| Biofrontera INC. | $239.78 | 2019-2025 | Ameluz, Xepi, Bf-Rhodoled |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Pucevich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.